Holdings (Monthly)
Guide ↗
Select Health Care Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY and CO | 532457108 | Feb 2026 | 408,000 | $429.2M | 6.93% | EC |
| 2 | DANAHER CORP | 235851102 | Feb 2026 | 1,880,000 | $396.0M | 6.39% | EC |
| 3 | BOSTON SCIENTIFIC CORP | 101137107 | Feb 2026 | 4,850,000 | $372.7M | 6.01% | EC |
| 4 | JOHNSON and JOHNSON | 478160104 | Feb 2026 | 1,400,000 | $347.8M | 5.61% | EC |
| 5 | ABBVIE INC | 00287Y109 | Feb 2026 | 1,140,000 | $264.6M | 4.27% | EC |
| 6 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 224,531,147 | $224.6M | 3.62% | STIV |
| 7 | ASCENDIS PHARMA A/S | 04351P101 | Feb 2026 | 716,000 | $167.2M | 2.70% | EC |
| 8 | UCB SA | N/A | Feb 2026 | 540,000 | $161.0M | 2.60% | EC |
| 9 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 1,080,000 | $160.9M | 2.60% | EC |
| 10 | MERCK and CO INC | 58933Y105 | Feb 2026 | 1,280,000 | $158.5M | 2.56% | EC |
| 11 | ARGENX SE | 04016X101 | Feb 2026 | 200,000 | $153.4M | 2.48% | EC |
| 12 | EDWARDS LIFESCIENCES CORP | 28176E108 | Feb 2026 | 1,600,000 | $138.4M | 2.23% | EC |
| 13 | CVS HEALTH CORP | 126650100 | Feb 2026 | 1,500,000 | $119.8M | 1.93% | EC |
| 14 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Feb 2026 | 340,000 | $113.2M | 1.83% | EC |
| 15 | THERMO FISHER SCIENTIFIC INC | 883556102 | Feb 2026 | 212,000 | $110.5M | 1.78% | EC |
| 16 | COGENT BIOSCIENCES INC | 19240Q201 | Feb 2026 | 2,560,000 | $99.5M | 1.60% | EC |
| 17 | MCKESSON CORP | 58155Q103 | Feb 2026 | 95,000 | $93.8M | 1.51% | EC |
| 18 | BRIGHTSPRING HEALTH SERVICES INC | 10950A106 | Feb 2026 | 2,080,000 | $86.2M | 1.39% | EC |
| 19 | MODERNA INC | 60770K107 | Feb 2026 | 1,600,000 | $85.7M | 1.38% | EC |
| 20 | INSMED INC | 457669307 | Feb 2026 | 560,000 | $83.6M | 1.35% | EC |
| 21 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Feb 2026 | 2,819,500 | $82.8M | 1.34% | EC |
| 22 | UNITEDHEALTH GROUP INC | 91324P102 | Feb 2026 | 280,000 | $82.1M | 1.33% | EC |
| 23 | NUVALENT INC | 670703107 | Feb 2026 | 760,000 | $77.5M | 1.25% | EC |
| 24 | ROCHE HOLDING AG | N/A | Feb 2026 | 160,000 | $76.1M | 1.23% | EC |
| 25 | CENCORA INC | 03073E105 | Feb 2026 | 200,000 | $74.4M | 1.20% | EC |
| 26 | ROYALTY PHARMA PLC | N/A | Feb 2026 | 1,500,000 | $69.3M | 1.12% | EC |
| 27 | INSULET CORP | 45784P101 | Feb 2026 | 270,000 | $66.6M | 1.07% | EC |
| 28 | WAYSTAR HOLDING CORP | 946784105 | Feb 2026 | 2,500,000 | $64.1M | 1.03% | EC |
| 29 | VAXCYTE INC | 92243G108 | Feb 2026 | 1,000,000 | $61.7M | 1.00% | EC |
| 30 | CARIS LIFE SCIENCES INC | 142152107 | Feb 2026 | 3,050,000 | $61.4M | 0.99% | EC |
| 31 | STRYKER CORP | 863667101 | Feb 2026 | 150,000 | $58.1M | 0.94% | EC |
| 32 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 1,290,000 | $55.8M | 0.90% | EC |
| 33 | REPLIGEN CORP | 759916109 | Feb 2026 | 428,000 | $55.1M | 0.89% | EC |
| 34 | VEEVA SYS INC | 922475108 | Feb 2026 | 300,000 | $54.6M | 0.88% | EC |
| 35 | PRIVIA HEALTH GROUP INC | 74276R102 | Feb 2026 | 2,280,000 | $54.1M | 0.87% | EC |
| 36 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Feb 2026 | 160,000 | $53.9M | 0.87% | EC |
| 37 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 2,800,000 | $53.2M | 0.86% | EC |
| 38 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 1,280,000 | $52.6M | 0.85% | EC |
| 39 | INTUITIVE SURGICAL INC | 46120E602 | Feb 2026 | 100,000 | $50.4M | 0.81% | EC |
| 40 | MEDLINE INC | 58507V107 | Feb 2026 | 1,000,000 | $47.5M | 0.77% | EC |
| 41 | CG ONCOLOGY INC | 156944100 | Feb 2026 | 800,000 | $47.0M | 0.76% | EC |
| 42 | CENTESSA PHARMACEUTICALS PLC | 152309100 | Feb 2026 | 1,650,000 | $44.3M | 0.72% | EC |
| 43 | DISC MEDICINE INC | 254604101 | Feb 2026 | 650,000 | $43.3M | 0.70% | EC |
| 44 | SPYRE THERAPEUTICS INC | 00773J202 | Feb 2026 | 940,000 | $40.4M | 0.65% | EC |
| 45 | STRUCTURE THERAPEUTICS INC | 86366E106 | Feb 2026 | 620,000 | $39.0M | 0.63% | EC |
| 46 | ALIGNMENT HEALTHCARE INC | 01625V104 | Feb 2026 | 2,000,000 | $38.4M | 0.62% | EC |
| 47 | ENLIVEN THERAPEUTICS INC | 29337E102 | Feb 2026 | 1,280,000 | $38.0M | 0.61% | EC |
| 48 | VERACYTE INC | 92337F107 | Feb 2026 | 1,030,144 | $37.7M | 0.61% | EC |
| 49 | CYTOKINETICS INC | 23282W605 | Feb 2026 | 600,000 | $37.3M | 0.60% | EC |
| 50 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,280,000 | $37.0M | 0.60% | EC |
| 51 | 10X GENOMICS INC | 88025U109 | Feb 2026 | 1,600,000 | $36.9M | 0.60% | EC |
| 52 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 800,000 | $35.6M | 0.57% | EC |
| 53 | ORUKA THERAPEUTICS INC | 687604108 | Feb 2026 | 1,006,510 | $34.6M | 0.56% | EC |
| 54 | OLEMA PHARMACEUTICALS INC | 68062P106 | Feb 2026 | 1,350,000 | $32.7M | 0.53% | EC |
| 55 | LIFESTANCE HEALTH GROUP INC | 53228F101 | Feb 2026 | 4,500,000 | $32.6M | 0.53% | EC |
| 56 | BIONTECH SE | 09075V102 | Feb 2026 | 280,000 | $30.9M | 0.50% | EC |
| 57 | MINERALYS THERAPEUTICS INC | 603170101 | Feb 2026 | 1,000,000 | $29.3M | 0.47% | EC |
| 58 | CIGNA GROUP (THE) | 125523100 | Feb 2026 | 100,000 | $29.0M | 0.47% | EC |
| 59 | BEONE MEDICINES LTD | 07725L102 | Feb 2026 | 90,000 | $28.5M | 0.46% | EC |
| 60 | ZENAS BIOPHARMA INC | 98937L105 | Feb 2026 | 1,080,000 | $28.5M | 0.46% | EC |
| 61 | SARTORIUS STEDIM BIOTECH | N/A | Feb 2026 | 128,000 | $27.7M | 0.45% | EC |
| 62 | STOKE THERAPEUTICS INC | 86150R107 | Feb 2026 | 750,000 | $27.3M | 0.44% | EC |
| 63 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 670,000 | $23.8M | 0.38% | EC |
| 64 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 23,324,912 | $23.3M | 0.38% | STIV |
| 65 | PHARVARIS BV | N/A | Feb 2026 | 800,000 | $22.7M | 0.37% | EC |
| 66 | WAVE LIFE SCIENCES LTD | N/A | Feb 2026 | 1,600,000 | $22.3M | 0.36% | EC |
| 67 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 243,586 | $22.3M | 0.36% | EC |
| 68 | HEARTFLOW INC | 42238D107 | Feb 2026 | 950,000 | $22.0M | 0.36% | EC |
| 69 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 1,420,000 | $21.5M | 0.35% | EC |
| 70 | KESTRA MEDICAL TECHNOLOGIES INC | N/A | Feb 2026 | 900,000 | $21.0M | 0.34% | EC |
| 71 | VIKING THERAPEUTICS INC | 92686J106 | Feb 2026 | 600,000 | $20.3M | 0.33% | EC |
| 72 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 118,000 | $19.3M | 0.31% | EC |
| 73 | CYTOMX THERAPEUTICS INC | 23284F105 | Feb 2026 | 3,400,000 | $18.3M | 0.29% | EC |
| 74 | GUARDANT HEALTH INC | 40131M109 | Feb 2026 | 194,000 | $18.2M | 0.29% | EC |
| 75 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 1,000,000 | $16.6M | 0.27% | EC |
| 76 | TRAVERE THERAPEUTICS INC | 89422G107 | Feb 2026 | 550,000 | $16.4M | 0.26% | EC |
| 77 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Feb 2026 | 500,000 | $16.1M | 0.26% | EC |
| 78 | CLEERLY INC | N/A | Feb 2026 | 1,285,367 | $16.1M | 0.26% | EP |
| 79 | SOLENO THERAPEUTICS INC | 834203309 | Feb 2026 | 400,000 | $15.6M | 0.25% | EC |
| 80 | GALECTO INC | 36322Q206 | Feb 2026 | 500,000 | $14.8M | 0.24% | EC |
| 81 | TREVI THERAPEUTICS INC | 89532M101 | Feb 2026 | 1,000,000 | $11.9M | 0.19% | EC |
| 82 | MIRUM PHARMACEUTICALS INC | 604749101 | Feb 2026 | 128,000 | $11.8M | 0.19% | EC |
| 83 | 10X GENOMICS INC | N/A | Feb 2026 | 500,000 | $11.5M | 0.19% | EC |
| 84 | IQVIA HOLDINGS INC | 46266C105 | Feb 2026 | 60,000 | $10.7M | 0.17% | EC |
| 85 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 316,310 | $10.6M | 0.17% | EP |
| 86 | OMADA HEALTH INC | 68170A108 | Feb 2026 | 850,000 | $10.4M | 0.17% | EC |
| 87 | REVOLUTION MEDICINES INC | 76155X100 | Feb 2026 | 100,000 | $10.2M | 0.16% | EC |
| 88 | BIOGEN INC | 09062X103 | Feb 2026 | 50,000 | $9.6M | 0.15% | EC |
| 89 | MBX BIOSCIENCES INC | 55287L101 | Feb 2026 | 280,000 | $9.1M | 0.15% | EC |
| 90 | KARDIUM INC/US | N/A | Feb 2026 | 15,888,877 | $9.1M | 0.15% | EP |
| 91 | ENDEAVOR BIOMEDICINES INC | N/A | Feb 2026 | 1,366,212 | $8.9M | 0.14% | EP |
| 92 | INSIGHTEC LTD | N/A | Feb 2026 | 11,853,768 | $8.9M | 0.14% | EP |
| 93 | UNIQURE N.V. | N/A | Feb 2026 | 540,000 | $8.4M | 0.14% | EC |
| 94 | RAPPORT THERAPEUTICS INC | 75383L102 | Feb 2026 | 285,000 | $8.3M | 0.13% | EC |
| 95 | CONTINEUM THERAPEUTICS INC | 21217B100 | Feb 2026 | 450,000 | $6.9M | 0.11% | EC |
| 96 | ANNEXON INC | 03589W102 | Feb 2026 | 1,200,000 | $6.7M | 0.11% | EC |
| 97 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 572,265 | $6.4M | 0.10% | EP |
| 98 | UPSTREAM BIO INC | 91678A107 | Feb 2026 | 800,000 | $6.1M | 0.10% | EC |
| 99 | SHOULDER INNOVATIONS INC | N/A | Feb 2026 | 448,586 | $6.1M | 0.10% | EC |
| 100 | JADE BIOSCIENCES INC | 008064206 | Feb 2026 | 400,000 | $5.9M | 0.10% | EC |
| 101 | BIO TECHNE CORP | 09073M104 | Feb 2026 | 100,000 | $5.9M | 0.10% | EC |
| 102 | APOGEE THERAPEUTICS INC | 03770N101 | Feb 2026 | 79,691 | $5.6M | 0.09% | EC |
| 103 | ALEDADE INC | N/A | Feb 2026 | 201,220 | $5.4M | 0.09% | EP |
| 104 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 869,000 | $5.4M | 0.09% | EP |
| 105 | OUTSET MEDICAL INC | 690145206 | Feb 2026 | 1,520,000 | $5.3M | 0.09% | EC |
| 106 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Feb 2026 | 116,515 | $5.2M | 0.08% | EC |
| 107 | KARDIUM INC/US | N/A | Feb 2026 | 3,997,150 | $4.6M | 0.07% | DBT |
| 108 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 494,535 | $4.4M | 0.07% | EC |
| 109 | HEAL TUB HOLDINGS LLC | N/A | Feb 2026 | 12,300 | $4.4M | 0.07% | EC |
| 110 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 160,865 | $4.2M | 0.07% | EC |
| 111 | CANDID THERAPEUTICS | N/A | Feb 2026 | 3,162,302 | $3.8M | 0.06% | EP |
| 112 | MANUS BIO INC | N/A | Feb 2026 | 1,079,396 | $3.6M | 0.06% | EP |
| 113 | ACUMEN PHARMACEUTICALS INC | 00509G209 | Feb 2026 | 1,140,000 | $3.6M | 0.06% | EC |
| 114 | ORUKA THERAPEUTICS INC | N/A | Feb 2026 | 103,500 | $3.6M | 0.06% | EC |
| 115 | PERCEPTIVE CAPITAL SOLUTIONS CORP | N/A | Feb 2026 | 320,567 | $3.2M | 0.05% | EC |
| 116 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | $3.1M | 0.05% | EP |
| 117 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | $3.1M | 0.05% | EP |
| 118 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 3,696,429 | $2.7M | 0.04% | EP |
| 119 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 5,823,768 | $2.6M | 0.04% | EP |
| 120 | ASIMOV INC | N/A | Feb 2026 | 101,438 | $2.6M | 0.04% | EP |
| 121 | SALUDA MEDICAL INC | N/A | Feb 2026 | 338,168 | $2.5M | 0.04% | EC |
| 122 | WUGEN INC | N/A | Feb 2026 | 2,299,153 | $2.4M | 0.04% | DBT |
| 123 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 1,748,893 | $2.3M | 0.04% | DBT |
| 124 | SURGERY PARTNERS INC | 86881A100 | Feb 2026 | 145,113 | $2.2M | 0.04% | EC |
| 125 | DMED BIOPHARMACEUTICAL CO LTD | N/A | Feb 2026 | 330,316 | $2.1M | 0.03% | EP |
| 126 | KARDIUM INC/US | N/A | Feb 2026 | 3,477,566 | $2.0M | 0.03% | EP |
| 127 | ALEDADE INC | N/A | Feb 2026 | 56,664 | $1.5M | 0.02% | EP |
| 128 | HEAL THRIVE HOLDINGS LLC | N/A | Feb 2026 | 473,270 | $1.4M | 0.02% | EC |
| 129 | SHOULDER INNOVATIONS INC | 82537J108 | Feb 2026 | 96,700 | $1.3M | 0.02% | EC |
| 130 | SALUDA MEDICAL INC | N/A | Feb 2026 | 1,600,000 | $1.2M | 0.02% | EC |
| 131 | IMMUNOME INC | 45257U108 | Feb 2026 | 46,826 | $1.0M | 0.02% | EC |
| 132 | WUGEN INC | N/A | Feb 2026 | 454,342 | $704K | 0.01% | EP |
| 133 | ELEVATEBIO, LLC | N/A | Feb 2026 | 254,900 | $517K | 0.01% | EP |
| 134 | KARDIUM INC/US | N/A | Feb 2026 | 723,517 | $412K | 0.01% | EP |
| 135 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 15,815 | $200K | 0.00% | EC |